Conservatives are challenging policies that allow doctors to consider race as a factor when allocating COVID treatments, and some states are dropping them.
), people of color in the U.S. face higher rates of COVID hospitalization and death than white people.announcing the filing of the lawsuit, America First Legal President Stephen Miller said:"New York's racist COVID decrees dispense lifesaving medicine based on the race or ethnic background of the patient. New York is deciding questions of life and death based on a New Yorker's ancestry. This is outrageously illegal, unconstitutional, immoral, and tyrannical.
The guidance related to race, she said"is based on CDC guidelines that show COVID-19 mortality rates are higher among certain demographic groups, including senior citizens, immunocompromised individuals and non-white/Hispanic communities." "It is important to note that no one in New York who is otherwise qualified based on their individual risk factors will be turned away from life-saving treatment because of their race or any demographic identifier," Silk wrote in an email.
On January 12, health officials in Minnesota removed race as a factor that medical professionals could use to determine which COVID patients can receive limited monoclonal antibody treatments. According to thethe policy shift occurred the same day that America First Legal threatened to sue Utah and Minnesota.
As conservatives challenge policies that have allowed medical professionals to weigh race as a factor when allocating scarce COVID-19 treatments, some states are dropping them. Above, medical workers treat a COVID patient in Hartford, Connecticut, on January 18.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Minnesota man dies from COVID-19 after family fought to keep his ventilator onA Buffalo, Minnesota man has died battling COVID-19, almost a week after being moved to Texas for care following a lawsuit over his ventilator.
Baca lebih lajut »
Utah eliminates race and sex as factors in monoclonal antibody COVID treatments after ‘legal concerns’After complaints by right-wing media personalities, Utah is eliminating race and sex as factors in allocating its limited supply of monoclonal antibodies and antiviral treatments for COVID-19.
Baca lebih lajut »
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severityUnlike antibodies elicited by mRNA vaccines against COVID19, some non-neutralizing, afucosylated IgG antibodies specific to SARSCoV2 may be associated with progression to more severe disease, according to new research in ScienceTM.
Baca lebih lajut »
Bay Area job market soars to big gains in December, defies COVID surgeThe Bay Area added jobs at a brisk pace in December, ending 2021 on a bright note that defied the fresh economic uncertainties unleashed by the omicron variant of the coronavirus.
Baca lebih lajut »
FDA acts to expand use of treatment for COVID-19 patients with mild-to-moderate diseasePreviously, the use of Veklury, a Gilead Sciences Inc. drug, was limited to those requiring hospitalization.
Baca lebih lajut »